Publications: Dr Judith Offman
Bancroft EK, Page EC, Brook MN, Pope J, Thomas S, Myhill K, Helfand BT, Talaty P et al.
(
2024
)
.
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers
.
BJU International
vol.
134
,
(
3
)
484
-
500
.
Tan WK, Maroni R, Offman J, Zamani SA, Team BT, di Pietro M, O’Donovan M, Muldrew B et al.
(
2024
)
.
Targeted Screening for Barrett’s Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial
.
Gastroenterology
vol.
167
,
(
4
)
798
-
800.e4
.
Tan WK, Maroni R, Offman J, Zamani S, Di Pietro M, O'Donovan M, Sasieni P, Fitzgerald RC
(
2024
)
.
861 MODELLING FROM A MULTICENTRE, PRAGMATIC, RANDOMISED CONTROLLED TRIAL IDENTIFIES THE TARGET SCREENING POPULATION AND EXPECTED YIELD FOR BARRETT'S ESOPHAGUS AND ESOPHAGEAL CANCER DIAGNOSES
.
Gastroenterology
vol.
166
,
(
5
)
s
-
196
.
Hill H, Kearns B, Pashayan N, Roadevin C, Sasieni P, Offman J, Duffy S
(
2023
)
.
The cost-effectiveness of risk-stratified breast cancer screening in the UK
.
British Journal of Cancer
.
vol.
129
,
1801
-
1809
.
Rumgay H, Cabasag CJ, Offman J, de Camargo Cancela M, Barchuk A, Mathur P, Wang S, Wei W et al.
(
2023
)
.
International burden of cancer deaths and years of life lost from cancer attributable to four major risk factors: a population-based study in Brazil, Russia, India, China, South Africa, the United Kingdom, and United States
.
EClinicalMedicine
vol.
66
,
Eastwood M, Sailem H, Marc ST, Gao X, Offman J, Karteris E, Fernandez AM, Jonigk D et al.
(
2023
)
.
MesoGraph: Automatic profiling of mesothelioma subtypes from histological images
.
Cell Reports Medicine
vol.
4
,
(
10
)
Ahmad AS, Offman J, Delon C, North BV, Shelton J, Sasieni PD
(
2023
)
.
Years of life lost due to cancer in the United Kingdom from 1988 to 2017
.
British Journal of Cancer
vol.
129
,
(
10
)
1558
-
1568
.
Dibden A, Offman J, Duffy SW, Gabe R
(
2023
)
.
Reply to Yaffe, M.J. Correction for Self-Selection in Breast Cancer Screening. Comment on “Dibden et al. Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality. Cancers 2020, 12, 976”
.
Cancers
vol.
15
,
(
18
)
Eastwood M, Marc ST, Gao X, Sailem H, Offman J, Karteris E, Fernandez AM, Jonigk D et al.
(
2023
)
.
Malignant Mesothelioma subtyping via sampling driven multiple instance prediction on tissue image and cell morphology data
.
Artificial Intelligence in Medicine
vol.
143
,
Ghimire B, Landy R, Maroni R, Smith SG, Debiram-Beecham I, Sasieni PD, Fitzgerald RC, Rubin G et al.
(
2023
)
.
Patient reported experiences of the Cytosponge test: Analysis of patient survey data from the BEST3 trial
.
Ghimire B, Landy R, Maroni R, Smith SG, Debiram-Beecham I, Sasieni PD, Fitzgerald RC, Rubin G et al.
(
2023
)
.
Predictors of the experience of a Cytosponge test: analysis of patient survey data from the BEST3 trial
.
BMC Gastroenterology
vol.
23
,
(
1
)
Eastwood M, Marc ST, Gao X, Sailem H, Offman J, Fernandez AM, Jonigk D, Cookson W et al.
(
2022
)
.
EP07.03-005 MesoGraph: Graph Neural Networks for Weakly Supervised Cellular Profiling in the Subtyping of Malignant Mesothelioma Images
.
Journal of Thoracic Oncology
vol.
17
,
(
9
)
s331
-
s332
.
Eastwood M, Marc ST, Gao X, Sailem H, Offman J, Karteris E, Fernandez AM, Jonigk D et al.
(
2022
)
.
Malignant Mesothelioma Subtyping of Tissue Images via Sampling Driven Multiple Instance Prediction
.
Artificial Intelligence in Medicine
,
vol.
13263
,
Springer Nature
Keith Tan W, Maroni R, Offman J, Pietro MD, Honing J, O’Donovan M, Sasieni P, Fitzgerald R
(
2022
)
.
O6 Ideal age to screen for Barrett’s oesophagus and oesophageal adenocarcinoma: modelling from the cytosponge-BEST3 trial
.
Conference:
Oral presentationsa3.2
-
a3a4
.
Maroni R, Barnes J, Offman J, Scheibl F, Smith SG, Debiram-Beecham I, Waller J, Sasieni P et al.
(
2022
)
.
Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial
.
BMJ Open
vol.
12
,
(
4
)
Eastwood M, Marc ST, Gao X, Sailem H, Offman J, Fernandez AM, Jonigk D, Cookson W et al.
(
2022
)
.
MesoGraph: Graph Neural Networks for Weakly Supervised Cellular Profiling in the Subtyping of Malignant Mesothelioma Images
.
JOURNAL OF THORACIC ONCOLOGY
.
vol.
17
,
S331
-
S332
.
Offman J, Pesola F, Fitzgerald RC, Hamilton W, Sasieni P
(
2021
)
.
Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study
.
Cancer Medicine
vol.
11
,
(
4
)
1160
-
1171
.
Bancroft EK, Page EC, Brook MN, Thomas S, Taylor N, Pope J, McHugh J, Jones A-B et al.
(
2021
)
.
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
.
The Lancet Oncology
vol.
22
,
(
11
)
1618
-
1631
.
Raghallaigh HN, Brook MN, Saunders EJ, Kumar P, Hazell S, Sohaib A, Dias A, Mcgrowder E et al.
(
2021
)
.
P0992 The PROFILE study. Targeted screening using germline genetics in men with a family history of prostate cancer
.
European Urology
vol.
79
,
Ni RH, Brook MN, Saunders EJ, Kumar P, Hazell S, Sohaib A, Dias A, Mcgrowder E et al.
(
2021
)
.
The PROFILE study. Targeted screening using germline genetics in men with a family history of prostate cancer
.
EUROPEAN UROLOGY
.
vol.
79
,
S1395
-
S1395
.
Fitzgerald RC, di Pietro M, O'Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, Gehrung M, Offman J et al.
(
2020
)
.
Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
.
The Lancet
vol.
396
,
(
10247
)
333
-
344
.
Fitzgerald RC, Di Pietro M, O'Donovan M, Muldrew B, Debiram-Beecham I, Offman J, Baseley L, Smith SG et al.
(
2020
)
.
634 RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-TFF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRECANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
.
Gastroenterology
vol.
158
,
(
6
)
s
-
136
.
Dibden A, Offman J, Duffy SW, Gabe R
(
2020
)
.
Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality
.
Cancers
vol.
12
,
(
4
)
Fitzgerald RC, Di Pietro M, O'Donovan M, Muldrew B, Debiram-Beecham I, Offman J, Baseley L, Smith SG et al.
(
2020
)
.
RESULTS FROM THE BARRETT'S OESOPHAGUS TRIAL 3 (BEST3): A RANDOMISED CONTROLLED TRIAL COMPARING THE CYTOSPONGE™-FF3 TEST WITH USUAL CARE TO IDENTIFY OESOPHAGEAL PRE-CANCER IN PRIMARY CARE PATIENTS WITH CHRONIC GASTROESOPHAGEAL REFLUX
.
GASTROENTEROLOGY
.
vol.
158
,
S136
-
S136
.
Page EC, Bancroft EK, Brook MN, Assel M, Al Battat MH, Thomas S, Taylor N, Chamberlain A et al.
(
2019
)
.
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
.
European Urology
vol.
76
,
(
6
)
831
-
842
.
Page E, Bancroft E, Brook M, Assel M, Offman J, Kote-Jarai Z, Vickers A, Lilja H et al.
(
2019
)
.
Interim results from the IMPACT study: evidence for PSA screening in <i>BRCA2</i> mutation carriers
.
BRITISH JOURNAL OF CANCER
.
vol.
121
,
13
-
13
.
Offman J, Muldrew B, O’Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, Smith SG, Wilson A et al.
(
2018
)
.
Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux
.
BMC Cancer
vol.
18
,
(
1
)
Bancroft EK, Saya S, Page EC, Myhill K, Thomas S, Pope J, Chamberlain A, Hart R et al.
(
2018
)
.
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
.
BJU International
vol.
123
,
(
2
)
284
-
292
.
Wilson A, -Beecham ID, Bowers B, Muldrew B, Aigret B, O'Donovan M, Tripathi M, Offman J et al.
(
2018
)
.
Sa1643 - Feasibility of the Implementation of Cytosponge as a Triage Test for Reflux Symptoms in Primary Care: Barrett's Esophagus Screening Trial 3 (Best3)
.
Gastroenterology
vol.
154
,
(
6
)
s
-
339
.
OFFMAN JM, PESOLA F, SASIENI P
(
2018
)
.
Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
.
British Journal of Cancer
Wilson A, Debiram-Beecham I, Bowers B, Muldrew B, Aigret B, O'Donovan M, Tripathi M, Offman J et al.
(
2018
)
.
FEASIBILITY OF THE IMPLEMENTATION OF CYTOSPONGE AS A TRIAGE TEST FOR REFLUX SYMPTOMS IN PRIMARY CARE: BARRETT'S ESOPHAGUS SCREENING TRIAL 3 (BEST3)
.
GASTROENTEROLOGY
.
vol.
154
,
S339
-
S339
.
Allgood, MARONI R, Hudson S, Offman, Turnbull AE, Peacock L, Steel J, Kirby G et al.
(
2017
)
.
The effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial
.
Lancet Oncology
Offman J, Fitzgerald RC
(
2017
)
.
Alternatives to Traditional Per-Oral Endoscopy for Screening
.
Gastrointestinal Endoscopy Clinics of North America
vol.
27
,
(
3
)
379
-
396
.
Freeman M, OFFMAN JM, Walter FM, Sasieni P, Smith SG
(
2017
)
.
Acceptability of the Cytosponge procedure for detecting Barrett's oesophagus: a qualitative study
.
BMJ Open
vol.
7
,
Offman J, Pesola F, Fitzgerald R, Hamilton W, Sasieni P
(
2016
)
.
Incidence and progression of Barrett's oesophagus in clinical practice: A cohort analysis for planning of the Barrett's ESophagus Trial 3 (BEST3) comparing the Cytosponge-TFF3 test with usual care
.
European Journal of Surgical Oncology
vol.
42
,
(
11
)
s252
-
s253
.
Sheringham J, Sequeira R, Myles J, Hamilton W, McDonnell J, Offman J, Duffy S, Raine R
(
2016
)
.
Variations in GPs' decisions to investigate suspected lung cancer: a factorial experiment using multimedia vignettes
.
BMJ Quality & Safety
vol.
26
,
(
6
)
Allgood PC, Maxwell AJ, Hudson S, Offman J, Hutchison G, Beattie C, Tuano-Donnelly R, Threlfall A et al.
(
2016
)
.
A randomised trial of the effect of postal reminders on attendance for breast screening
.
British Journal of Cancer
vol.
114
,
(
2
)
171
-
176
.
Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T et al.
(
2015
)
.
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study
.
The Lancet Oncology
vol.
17
,
(
1
)
109
-
114
.
Gallina I, Colding C, Henriksen P, Beli P, Nakamura K, Offman J, Mathiasen DP, Silva S et al.
(
2015
)
.
Cmr1/WDR76 defines a nuclear genotoxic stress body linking genome integrity and protein quality control
.
Nature Communications
vol.
6
,
(
1
)
Gallina I, Colding CS, Henriksen P, Beli P, Nakamura K, Offman J, Mathiasen DP, Silva S et al.
(
2015
)
.
Regulation of homologous recombination
.
YEAST
.
vol.
32
,
S32
-
S32
.
Offman J, Sasieni P
(
2015
)
.
Trends in adenocarcinoma and squamous cell carcinoma of the oesophagus in England: 1970s to 2012
.
EUROPEAN JOURNAL OF CANCER CARE
vol.
24
,
13
-
13
.
Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, North BV, Shiel S et al.
(
2014
)
.
A telephone reminder intervention to improve breast screening information and access
.
Public Health
vol.
128
,
(
11
)
1017
-
1022
.
Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, North BV, Shiel S et al.
(
2014
)
.
A telephone reminder intervention to improve breast screening information and access
.
Public Health
vol.
128
,
(
11
)
1017
-
1022
.
Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S et al.
(
2013
)
.
Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme
.
British Journal of Cancer
vol.
110
,
(
3
)
560
-
564
.
Offman J, Wilson M, Lamont M, Birke H, Kutt E, Marriage S, Loughrey Y, Hudson S et al.
(
2013
)
.
A randomised trial of weekend and evening breast screening appointments
.
British Journal of Cancer
vol.
109
,
(
3
)
597
-
602
.
Offman J
(
2013
)
.
Confronting Hereditary Breast and Ovarian Cancer: Identify Your Risk, Understand Your Options, Change Your Destiny
.
BMJ Sexual & Reproductive Health
vol.
39
,
(
1
)
Tabar L, Lindhe N, Yen AMF, Chen THH, Chiu SYH, Fann JCY, Chen SLS, Wu GHM et al.
(
2012
)
.
Radiotherapy After Surgery for Small Breast Cancers of Stellate Appearance
.
Imaging of the Breast - Technical Aspects and Clinical Implication
,
IntechOpen
Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, Duffy SW
(
2011
)
.
Mammographic density and its interaction with other breast cancer risk factors in an Asian population
.
British Journal of Cancer
vol.
104
,
(
5
)
871
-
874
.
Duffy SW, Mackay J, Thomas S, Anderson E, Evans DG, Fielder H, Fox R, Gray J et al.
(
2010
)
.
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
.
LANCET ONCOL
vol.
11
,
(
12
)
1127
-
1134
.
Clyne M, Offman J, Shanley S, Virgo JD, Radulovic M, Wang Y, Ardern-Jones A, Eeles R et al.
(
2009
)
.
The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome
.
British Journal of Cancer
vol.
100
,
(
2
)
376
-
380
.
Offman J, Jina N, Theron T, Pallas J, Hubank M, Lehmann A
(
2008
)
.
Transcriptional changes in trichothiodystrophy cells
.
DNA Repair
vol.
7
,
(
8
)
1364
-
1371
.
Botta E, Offman J, Nardo T, Ricotti R, Zambruno G, Sansone D, Balestri P, Raams A et al.
(
2006
)
.
Mutations in the C7orf11 (TTDN1) gene in six nonphotosensitive trichothiodystrophy patients: no obvious genotype–phenotype relationships
.
Human Mutation
vol.
28
,
(
1
)
92
-
96
.
Offman J, Gascoigne K, Bristow F, Macpherson P, Bignami M, Casorelli I, Leone G, Pagano L et al.
(
2005
)
.
Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome
.
Molecular Cancer Research
vol.
3
,
(
5
)
251
-
260
.
Offman J, Opelz G, Doehler B, Cummins D, Halil O, Banner NR, Burke MM, Sullivan D et al.
(
2004
)
.
Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation
.
Blood
vol.
104
,
(
3
)
822
-
828
.
Karran P, Offman J, Bignami M
(
2003
)
.
Human mismatch repair, drug-induced DNA damage, and secondary cancer
.
Biochimie
vol.
85
,
(
11
)
1149
-
1160
.
Casorelli I, Offman J, Mele L, Pagano L, Sica S, D’Errico M, Giannini G, Leone G et al.
(
2003
)
.
Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome
.
DNA Repair
vol.
2
,
(
5
)
547
-
559
.
Massey A, Offman J, Macpherson P, Karran P
(
2003
)
.
DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells
.
DNA Repair
vol.
2
,
(
1
)
73
-
89
.
Casorelli I, Offman J, Mele L, Pagano L, Sica S, Leone G, Karran P, Bignami M
(
2001
)
.
Mismatch repair defects among italian cases of secondary acute leukemia and myelodysplastic syndrome
.
European Journal of Cancer
vol.
37
,